NAFDAC alerts Nigerians on fake and deadly injection in circulation

The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians, particularly healthcare providers, to one batch of counterfeit Meronem 1g Injection being purchased in Nigeria.

The information is contained in a public alert No. 036/2023, signed by the agency’s Director-General, Prof. Mojisola Adeyeye, and issued in Abuja on Tuesday, November 21, 2023.

Adeyeye said the Marketing Authorization Holder (MAH), Pfizer, reported the incident, as received through a patient notification platform, concerning a suspicious Meronem 1g injection purchase.

The D-G said that the production process did not meet Pfizer’s specifications.

“The vial label compares favourably to the purported artwork version.

“Meronem (Meropenem trihydrate injection) is an antibiotic used to treat skin and abdominal (stomach area) infections caused by bacteria and meningitis (infection of the membranes that surround the brain and spinal cord) in adults and children 3 months of age and older.

“The administration of the counterfeit product will pose a high risk to patients as the quality and safety are not guaranteed,” Adeyeye said.

The NAFDAC boss, however, said that healthcare providers and patients were advised to obtain all medical products from authorized or licensed suppliers.

According to her, products’ authenticity and physical condition should be carefully checked before purchase and administration.

Culled from PM